Summary
Latest filing:
Vuong Trieu is CHAIRMAN AND CEO, Director, 10% Owner of Oncotelic Therapeutics, Inc. (OTLC). 8 SEC Form 4 filings on record going back to 2024, most recently on 14 July 2026. Most recent open-market trade: bought $10K of OTLC on 2 July 2026. Lifetime open-market purchases: $46K. Historical track record: 1/5 stars across 4 tracked purchases.
Recent Transactions
10Every recent SEC Form 4 transaction Vuong Trieu has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 25% |
| 90-day win rate | 100% |
| Avg 5-day return | +3.57% |
| Avg 30-day return | -6.76% |
| Avg 90-day return | +62.46% |
| Best 30-day return | +3.23% |
Trading Pattern
InsiderAlpha's records for Vuong Trieu go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. The typical open-market purchase is $5K (10 buys totaling $46K). The largest single buy on record is $11K of OTLC in 2026. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Vuong Trieu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amit B. Shah - $1K of OTLC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Vuong Trieu?
Vuong Trieu is a corporate insider, tracked as CHAIRMAN AND CEO, Director, 10% Owner of Oncotelic Therapeutics, Inc. (OTLC). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Vuong Trieu submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Vuong Trieu been buying or selling stock?
Recorded transactions: 10 open-market purchases ($46K) and 0 open-market sales across all tracked filings.
How accurate is Vuong Trieu's historical track record?
Across 4 tracked purchases, Vuong Trieu averaged -6.8% avg 30-day return with a 25% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
Where can I see all of Vuong Trieu's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Vuong Trieu and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial